Search results for "Absolute"

showing 10 items of 518 documents


 Interventions to Reduce Platelet Prophylactic Transfusions in Patients with Hypoproliferative Thrombocytopenia: Providing Patients with the Fu…

2013

SUMMARY To reduce the infectious and immunologic complications of platelet transfusions in patients with hypoproliferative thrombocytopenia, three interventions have aimed to decrease the number of prophylactic platelet transfusions received by such patients for the prevention of bleeding. These are the reduction of the platelet count threshold triggering prophylactic transfusion, the administration of low-dose (as opposed to standard-dose) platelet transfusions, and the administration of therapeutic (as opposed to prophylactic) platelet transfusions. We demonstrate that—in terms of absolute risk reduction in all infectious and some immunologic complications of transfusion— patients can ben…

medicine.medical_specialtyBlood managementStandard of carebusiness.industryInternal medicineAbsolute risk reductionPsychological interventionMedicineIn patientPlateletbusinessGeneral Biochemistry Genetics and Molecular BiologySurgeryClinical Laboratory
researchProduct

Granulocyte–Macrophage Colony-Stimulating Factor in the Therapy of Adults with De Novo Acute Myeloblastic Leukemia: An Update of a Double-Blind Rando…

1997

We investigated whether granulocytemacrophage colony-stimulating factor (GMCSF) given concomitantly with chemotherapy (CT) improves the outcome of adults with de novo acute myeloblastic leukemia (AML) by increasing the efficacy of CT and reducing infections. CT included cytarabine (ara-C) daunorubicin, and etoposide (DAV) for induction and early consolidation therapy and one cycle with high-dose (patients aged ≤50 years) or intermediate-dose ara-C (patients aged >50 years) /daunorubicin for late consolidation therapy. Eighty patients were randomized after DAV 1 to receive either GM-CSF (Escherichia coli, 250 µg/m2 per day, s.c.) or placebo starting 48 h prior to DAV II and the subsequent co…

medicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentPlacebo-controlled studyPlaceboGastroenterologyExact testMedian follow-upInternal medicineCytarabinemedicineAbsolute neutrophil countPhysical therapybusinessEtoposidemedicine.drug
researchProduct

Calculating confidence intervals for impact numbers

2006

Abstract Background Standard effect measures such as risk difference and attributable risk are frequently used in epidemiological studies and public health research to describe the effect of exposures. Recently, so-called impact numbers have been proposed, which express the population impact of exposures in form of specific person or case numbers. To describe estimation uncertainty, it is necessary to calculate confidence intervals for these new effect measures. In this paper, we present methods to calculate confidence intervals for the new impact numbers in the situation of cohort studies. Methods Beside the exposure impact number (EIN), which is equivalent to the well-known number needed …

medicine.medical_specialtyEpidemiologyCoronary DiseaseHealth InformaticsRisk AssessmentCohort StudiesJapanRisk FactorsEpidemiologyStatisticsConfidence IntervalsmedicineHumanslcsh:R5-920business.industrySmokingUncertaintyAbsolute risk reductionUnited KingdomConfidence intervalStrokeSample size determinationSample SizeAttributable riskNumber needed to treatlcsh:Medicine (General)Risk assessmentbusinessResearch ArticleCohort studyBMC Medical Research Methodology
researchProduct

Calculation of NNTs in RCTs with time-to-event outcomes: A literature review

2008

Abstract Background The number needed to treat (NNT) is a well-known effect measure for reporting the results of clinical trials. In the case of time-to-event outcomes, the calculation of NNTs is more difficult than in the case of binary data. The frequency of using NNTs to report results of randomised controlled trials (RCT) investigating time-to-event outcomes and the adequacy of the applied calculation methods are unknown. Methods We searched in PubMed for RCTs with parallel group design and individual randomisation, published in four frequently cited journals between 2003 and 2005. We evaluated the type of outcome, the frequency of reporting NNTs with corresponding confidence intervals,…

medicine.medical_specialtyEpidemiologyMEDLINEHealth Informaticslaw.inventionRandomized controlled triallawStatisticsConfidence IntervalsHumansMedicineRandomized Controlled Trials as Topiclcsh:R5-920business.industryAbsolute risk reductionConsolidated Standards of Reporting TrialsConfidence intervalClinical trialSample size determinationData Interpretation StatisticalSample SizeNumber needed to treatPhysical therapylcsh:Medicine (General)businessResearch ArticleBMC Medical Research Methodology
researchProduct

Otoacoustic emissions: a new method to diagnose hearing impairment in children.

1993

Otoacoustic emissions (OAEs) are epiphenomena of sensitive, amplifying processes during hearing which can be detected in persons with normal inner ear function. They originate from the cochlea and are interpreted as an energy leakage of cochlear processes, perhaps resulting from active outer hair cell movements. OAEs travel from the cochlea through the middle ear to the external auditory canal where they can be detected using sensitive miniature microphones. Transient evoked (TEOAE) tests allow to otoacoustic emissions non-invasively check the integrity of the cochlea. In the neonatal period, registration of OAEs can be accomplished during natural sleep. In infants and neonates TEOAEs can b…

medicine.medical_specialtyHearing lossHearing Loss SensorineuralOtoacoustic Emissions SpontaneousAudiologyotorhinolaryngologic diseasesmedicineAnimalsHumansInner earChildHearing DisordersCochleaAbsolute threshold of hearingmedicine.diagnostic_testbusiness.industryInfant NewbornAudiometry Evoked ResponseHearing disordermedicine.anatomical_structurePediatrics Perinatology and Child HealthMiddle earsense organsHair cellAudiometrymedicine.symptombusinessEuropean journal of pediatrics
researchProduct

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis

2018

Aims Controversial reports exist in the literature regarding the prognostic role and therapeutic implications of syncope in patients with acute pulmonary embolism (PE). We conducted a systematic review and meta-analysis to investigate the association between syncope and short-term adverse outcomes, taking into account the presence or absence of haemodynamic compromise at acute PE presentation. Methods and results The literature search identified 1664 studies, 29 of which were included for a total of 21 956 patients with PE (n = 3706 with syncope). Syncope was associated with higher prevalence of haemodynamic instability [odds ratio (OR) 3.50; 95% confidence interval (CI) 2.67-4.58], as well…

medicine.medical_specialtyHemodynamicsBlood Pressure030204 cardiovascular system & hematologyGlobal HealthSyncopeRisk-stratification03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineMortalityRight ventricular dysfunctionbiologybusiness.industryIncidence (epidemiology)IncidencePulmonary embolismSyncope (genus)Absolute risk reductionOdds ratiomedicine.diseasebiology.organism_classificationPrognosisConfidence interval3. Good healthPulmonary embolismSurvival RateEchocardiographyMeta-analysisAcute DiseasebusinessCardiology and Cardiovascular Medicine
researchProduct

Systematic search for neutropenia should be part of the first screening in patients with poikiloderma.

2011

Poikiloderma occurs in a number of hereditary syndromes, the best known of which is Rothmund-Thomson syndrome (RTS). Differential diagnoses include Dyskeratosis Congenita (DC) with high genetic heterogeneity and Clericuzio-type Poikiloderma with Neutropenia (CPN) due to mutations in the C16orf57 gene. Mutations in the RECQL4 gene are only observed in two thirds of RTS patients. In this study, 10 patients referred for syndromic poikiloderma and negative for RECQL4 sequencing analysis were investigated for C16orf57 mutations. Two C16orf57 heterozygous nonsense mutations (p.W81X and p.Y89X) were identified in a 5-year-old female child presenting with generalized poikiloderma, dental dysplasia,…

medicine.medical_specialtyHeterozygoteNeutropeniaNonsense mutationPoikilodermaNeutropeniaDiagnosis DifferentialGeneticsmedicineHumansAbnormalities MultipleGenetic TestingGenetics (clinical)Genetic testingRetrospective StudiesGeneticsmedicine.diagnostic_testRecQ HelicasesGenetic heterogeneitybusiness.industryRothmund-Thomson SyndromeGeneral Medicinemedicine.diseaseDermatologyPedigreePalmoplantar keratodermaCodon NonsenseChild PreschoolAbsolute neutrophil countErythrocyte CountFemalebusinessDyskeratosis congenitaEuropean journal of medical genetics
researchProduct

Interaction of cerebrovascular disease and contralateral carotid occlusion in prediction of shunt insertion during carotid endarterectomy

2012

INTRODUCTION To assess the possible role and the interaction of cerebrovascular disease and vascular stenosis on the necessity of shunt insertion during carotid endarterectomy (CEA). MATERIAL AND METHODS Eighty consecutive patients undergoing CEA under regional anaesthesia were prospectively enrolled. Patients were divided into two groups depending on whether they were shunted or not. The measured end-points were co-morbidities degree of contralateral and carotid stenosis and other intra- and postoperative outstanding parameters. ANOVA, Student's t and χ(2) tests were used (p<0.05). Variables differing significantly between groups and potential confounders were used in backward stepwise log…

medicine.medical_specialtyMultivariate analysiscerebral ischaemiabusiness.industrymedicine.medical_treatmentConfoundingAbsolute risk reductionGeneral MedicineCarotid endarterectomyStepwise regressionmedicine.diseaseSurgeryStenosisClinical ResearchInternal medicineRelative riskmedicineCardiologyshunted patientsbusinessVascular Stenosiscarotid endarterectomyArchives of Medical Science : AMS
researchProduct

Lymph node evaluation for resected colorectal cancer

2013

SUMMARY The negative impact of regional lymph node metastasis on survival from nonmetastatic colorectal cancers is proportional to the number of nodes harvested. A thorough lymph node examination by the pathologist is essential for accurate staging. Recommendations in the USA and Europe stipulate that a minimum of 12–15 lymph nodes must be examined to accurately predict regional node negativity. The prognostic separation for stage III colorectal cancer obtained by the lymph node ratio is superior to that of the absolute number of positive nodes. The extent of mesenteric resection, pathologic technique, age or tumor location may influence lymph node yield. In the future, biological signific…

medicine.medical_specialtyPathologyAbsolute numberColorectal cancerbusiness.industryGastroenterologymedicine.diseaseResectionmedicine.anatomical_structureOncologyBiological significanceNode (computer science)medicineRadiologyLymphTumor locationbusinessLymph nodeColorectal Cancer
researchProduct

Escitalopram for the prevention of peginterferon-alpha2a-associated depression in hepatitis C virus-infected patients without previous psychiatric di…

2012

BACKGROUND: Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-alpha (IFN-alpha). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors. OBJECTIVE: To examine whether preemptive antidepressant treatment with escitalopram can decrease the incidence or severity of depression associated with pegylated IFN-alpha in HCV-infected patients without a history of psychiatric disorders. DESIGN: Randomized, multicenter, double-blind, prospective, placebo-controlled, parallel-group trial. (ClinicalTrials.gov registration number: NCT00136318) SETTING: 10 university and 11 academic…

medicine.medical_specialtyPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineEscitalopram030212 general & internal medicinePsychiatryDepression (differential diagnoses)business.industryIncidence (epidemiology)Absolute risk reductionGeneral MedicineHepatitis Cmedicine.disease3. Good healthTolerability030211 gastroenterology & hepatologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct